New research from Oncogenesis

If you are unable to see the message below, click here to view.

Editor-in-Chief: Jan Paul Medema, Netherlands Oncogenesis is an online-only, open access, peer-reviewed journal that publishes full-length papers, reviews, and short communications exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. Visit the journal website to explore the latest content, or to explore the benefits of submitting your next manuscript. Research highlights: FLASH protects ZEB1 from degradation and supports cancer cells' epithelial-to-mesenchymal transition C F Abshire, J L Carroll and A-M Dragoi KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer T Hinoi et al. The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells S N Jones et al. Constitutively activated PI3K accelerates tumor initiation and modifies histopathology of breast cancer S Fiering et al. The Rho guanine nucleotide exchange factor ARHGEF5 promotes tumor malignancy via epithelial–mesenchymal transition M Okada et al. Submit your next manuscript to Oncogenesis and benefit from: High impact: Impact Factor 5.021* (5-year Impact Factor: 4.338*). Quality, reputation and a high standard of peer review. Open access: a recent study** indicates that open access articles may result in increased visibility and citation of your research. Wide dissemination: articles are published under a Creative Commons licence, permanently and freely available for all to read, use and cite without restriction, whilst authors retain the copyright to their article. Indexing and abstracting in leading databases, including PubMed, PubMed Central, Medline, Scopus, and Web of Science. Compliance with international open access funder mandates. Global reach through nature.com and widely distributed journal e-alert messages. Visit our website to find out more about open access funding options that may be available to you. About   Online Submission   Free e-alerts *2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016) **Research Information Network (RIN), 2014 As a registered user of Nature Publishing Group's Web sites, our database indicates that you have opted-in to receive product information and special offers. If you no longer wish to receive these e-mails or to discontinue all e-mail services from Nature Publishing Group please update your online account. Modify My Account (Log in to be recognised as a Nature.com registrant). For further information on technical assistance | print subscriptions | other enquiries. Nature Publishing Group | Principal offices: London | New York and Tokyo, and offices in cities worldwide including Basingstoke | Barcelona | Boston | Buenos Aires | Cairo | Delhi | Heidelberg | Madrid | Melbourne | Mexico City | Mumbai | Munich | Paris | San Francisco | Sao Paulo | Seoul | Shanghai and Washington DC. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | US © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All rights reserved.